Skip to main content
Caplight Logo









Concordare Trials

Concordare Trials

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://concordare.com/

Last Round

Seed

Aug 25, 2026

Total Funding Raised

$320,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Concordare Trials is a healthcare software company that develops a universal digital protocol to standardize clinical trial setup across software systems.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

protocol automationclinical trial automationdigital protocolclinical trial softwareAI for clinical trialseClinical solutionssite activationmachine-readable protocolClinical Protocol Template ModelCPTMcontract research organizationCROclinical operations softwarehealth techVertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concordare Trials Comparables

Compare Concordare Trials with similar companies based on industry and business-model similarity.

Concordare Trials comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Espero Health
82%
UniTriTeam
81%
Risklick AG
77%

Concordare Trials Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 25, 2026
AcceleratorMar 9, 2026
AcceleratorFeb 10, 2026

Concordare Trials Investors

Notable investors and investment history

Concordare Trials investors
InvestorRounds
TechstarsSeed, Accelerator
GaingelsSeed
Surface VenturesSeed
AlphaLabAccelerator
Innovation WorksAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    Seed round led by Surface Ventures with participation from Gaingels and Techstars.

Concordare Trials Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Concordare Trials Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concordare Trials's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Year Founded2024
Last FundingAug 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?